Diet can help reduce lipid levels in people with HAART-related dyslipemia
13 November 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Side effects
Lipodystrophy syndrome and self-assessment of wellbeing and physical appearance in HIV-positive patients
1 November 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Abacavir hypersensitivity reactions in patients who rechallenge after interruptions for reasons other than hypersensitivity
11 September 2002. Related: Conference reports, Side effects.
Prolonged CNS side-effects of efavirenz can be severe and lead to treatment discontinuation
11 September 2002. Related: Conference reports, Side effects.
Triglyceride increase can predict lipodystrophy in HIV patients under highly active antiretroviral therapy
11 September 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Peripheral neuropathy: new data on risk factors, incidence and association with viral load
11 September 2002. Related: Side effects.
High prevalence of osteonecrosis of the hip found in HIV-infection
11 September 2002. Related: Side effects.
In switch study, women twice as likely as men to discontinue HAART due to toxicities
11 July 2002. Related: Women's health, Side effects.
Neuropsychiatric complications of nevirapine treatment
11 June 2002. Related: Side effects.
Paracardial fat in HIV-infected patient resembles pericardial effusion
11 June 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Altered adipocyte differentiation associated with protease inhibitors and lipoatrophy
11 May 2002. Related: Side effects, Lipodystrophy and metabolic complications.
High mortality rate in patients with severe NRTI-associated lactic acidosis
11 May 2002. Related: Side effects.
Tenofovir adversely affects development in foetal monkeys
11 May 2002. Related: Side effects.
Tenofovir not toxic to mitochondria in human cell culture
11 May 2002. Related: Side effects.
Study results shed light on cardiovascular risks: role of antiretrovirals and metabolism of lipids and sugars
10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Switch to abacavir improves lipoatrophy
10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Potential use of niacin to reduce intra-abdominal fat
10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Further benefits shown with New-Fill for facial atrophy
10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Lipodystrophy associated with lower CD4+ T cell counts
10 April 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Peripheral neuropathy update
10 April 2002. Related: Conference reports, Side effects.
Leptin reverses lipodystrophy in diabetic patients
10 April 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Meeting calls for NHS funding and training to provide repair treatment for people with facial lipoatrophy
10 March 2002. Related: Special reports, Treatment access, Side effects, Lipodystrophy and metabolic complications.
Hepatic injury with nevirapine related to drug level and hepatitis C infection
10 March 2002. Related: Antiretrovirals, Side effects.
It may be important to screen and treat riboflavin deficiency in patients on nucleoside analogues
10 March 2002. Related: Antiretrovirals, Side effects.
Managing the metabolic side effects of antiretroviral therapy
10 March 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Intensive diet and exercise regimen may help fight lipodystrophy
10 March 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Avascular necrosis (AVN) may be increasingly common in HIV-positive patients
10 March 2002. Related: Side effects.
Rheumatological complications associated with the use of indinavir and other protease inhibitors
10 March 2002. Related: Side effects.
Doubt over use of antioxidant vitamins for the prevention of coronary disease
10 January 2002. Related: Side effects.
Endocrine disorders complicate ARV treatment
10 January 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Enteric coated didanosine significantly reduces nausea, bloating, GI upset
9 December 2001. Related: Antiretrovirals, Side effects.
Elevated blood pressure in subjects with lipodystrophy
9 December 2001. Related: Side effects.
Fat distribution is strongly tied to metabolic disturbances in HIV lipodystrophy
9 December 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Eating more often can reduce cholesterol levels
9 December 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Further reports of benefits of polylactic acid for facial lipoatrophy
2 November 2001. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV cohort study
2 November 2001. Related: Antiretrovirals, Side effects.
Preventable factors linked to indinavir-associated renal complications
2 November 2001. Related: Side effects.
Nerve growth factor improves HIV-associated sensory neuropathy
2 November 2001. Related: Side effects, Coinfections and complications.
Lipodystrophy in HAART-treated patients may have multifactorial aetiology
2 November 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Rapidly ascending neuromuscular weakness associated with nucleoside analogues
2 October 2001. Related: Treatment alerts, Side effects.
FDA requests changes in product information for all antiretrovirals
1 October 2001. Related: Side effects.
Dihydrotestosterone for HAART-associated breast enlargement in men
1 October 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Osteopenia seen in testosterone-deficient women with AIDS wasting
1 October 2001. Related: Women's health, Side effects, Lipodystrophy and metabolic complications.
Corticosteroids linked to HIV-associated osteonecrosis
1 October 2001. Related: Side effects.
Dietary factors, metabolic abnormalities and fat redistribution
1 October 2001. Related: Side effects, Lipodystrophy and metabolic complications.
High incidence of reduced bone density found in HIV positive people
1 October 2001. Related: Side effects.
Severe hepatic injury common after HAART initiation
1 October 2001. Related: Side effects, Hepatitis coinfection.
Lipodystrophy and metabolic complications
1 September 2001. Related: Conference reports, Side effects.
Lipodystrophy and metabolic disturbances
1 September 2001. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Adverse events with antiretrovirals
1 September 2001. Related: Conference reports, Side effects.
Carnitine for high triglycerides
1 September 2001. Related: Side effects.
Does efavirenz cause breast enlargement?
1 September 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Fat malabsorption common cause of diarrhoea in HIV-positive patients
1 September 2001. Related: Side effects.
Dietary supplements can help with nelfinavir-related diarrhoea
1 September 2001. Related: Side effects.
HCV coinfection may have role in changes in body composition in HIV patients
1 September 2001. Related: Side effects, Lipodystrophy and metabolic complications, Hepatitis coinfection.
Sexual dysfunction associated with protease inhibitor containing HAART
30 July 2001. Related: Side effects.
Nevirapine use linked to icteric hepatitis in some HIV-positive patients
30 July 2001. Related: Side effects.
Tattoos flare up from HAART
30 July 2001. Related: Side effects.
Treatment of hyperlipidemia in HIV-positive patients
30 July 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Self-reported symptoms after starting HAART help predict adherence
17 May 2001. Related: Antiretrovirals, Side effects.
Risk of lipodystrophy in HIV-positive treated with PIs: a prospective cohort study
17 April 2001. Related: Side effects, Lipodystrophy and metabolic complications.
Drugs need not be stopped because of neutropenia in HIV-positive patients
17 March 2001. Related: Antiretrovirals, Side effects.
Prevalence and correlates of anaemia in a large cohort of HIV-positive women
17 March 2001. Related: Women's health, Side effects.
HIV-related fatigue relieved by psychostimulants
17 March 2001. Related: Side effects.
Studies underway on metabolic side effects of antiretrovirals
17 March 2001. Related: Side effects, Lipodystrophy and metabolic complications.